Mantovani G, Macciò A, Pisano M, Versace R, Lai P, Esu S, Massa E, Ghiani M, Dessì D, Melis G B, Del Giacco G S
Department of Medical Oncology, University of Cagliari, Italy.
Int J Cancer. 1997 May 29;71(5):724-31. doi: 10.1002/(sici)1097-0215(19970529)71:5<724::aid-ijc6>3.0.co;2-t.
We studied several in vitro activities of tumor-associated lympho-monocytes (TALMs) and the concentrations of interleukin (IL)-1alpha, IL-1beta, IL-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)alpha, interferon (IFN)gamma and soluble IL-2 receptor (slL-2R) in neoplastic effusions and in the serum of advanced stage cancer patients. Comparisons were made with autologous peripheral blood mononuclear cells (PBMCs). Autologous PBMCs were compared with PBMCs from normal subjects used as controls. TALMs were collected from 13 peritoneal and 18 pleural neoplastic effusions, secondary to primary tumors of different sites. After PHA stimulation, concentrations of IL-1alpha, IL-1beta and TNF alpha in culture media of TALMs both from peritoneal and pleural effusions were lower than those of autologous PBMCs and, similarly, concentrations of IL-4 and IL-10 in culture media of TALMs from peritoneal effusions were lower than those of autologous PBMCs, whereas concentrations of IL-4 and IL-10 in culture media of TALMs from pleural effusions were in the same range as those of autologous PBMCs. On the contrary, IL-2, IL-6 and IFN gamma amounts (only from pleural effusions) were significantly higher. IL-1alpha, IL-1beta, IL-2, IL-6 and TNF alpha production from patient PBMCs was lower than that of control PBMCs, whereas production of IL-4, IL-10 and IFN gamma was higher than that of control PBMCs. Both in peritoneal and in pleural effusions concentrations of IL-1alpha, IL-1beta and IL-4 were not different from those measured in autologous serum, whereas those of IL-6, IL-10, TNF alpha, IFN gamma and sIL-2R were significantly higher. The amounts of IL-2 in pleural effusions were not different from those of autologous serum, but in peritoneal effusions they were higher than those of autologous serum. The amounts of IL-1alpha, IL-1beta, IL-2, IL-6, TNF alpha and sIL-2R were higher in patient than in control sera, whereas those of IL-4, IL-10 and IFN gamma were in the same range in patient and in control sera. Cell cycle analysis of cultured TALMs and PBMCs (from 3 patients) showed a significant accumulation of TALMs in the non-cycling G0/G1 cell population compared with autologous PBMCs.
我们研究了肿瘤相关淋巴细胞单核细胞(TALMs)的几种体外活性,以及晚期癌症患者肿瘤积液和血清中白细胞介素(IL)-1α、IL-1β、IL-2、IL-4、IL-6、IL-10、肿瘤坏死因子(TNF)α、干扰素(IFN)γ和可溶性IL-2受体(sIL-2R)的浓度。并与自体外周血单个核细胞(PBMCs)进行了比较。将自体PBMCs与作为对照的正常受试者的PBMCs进行了比较。TALMs取自13例因不同部位原发性肿瘤继发的腹腔肿瘤积液和18例胸腔肿瘤积液。经PHA刺激后,腹腔和胸腔积液中TALMs培养基中IL-1α、IL-1β和TNFα的浓度均低于自体PBMCs,同样,腹腔积液中TALMs培养基中IL-4和IL-10的浓度低于自体PBMCs,而胸腔积液中TALMs培养基中IL-4和IL-10的浓度与自体PBMCs处于同一范围。相反,IL-2、IL-6和IFNγ的量(仅来自胸腔积液)显著更高。患者PBMCs产生的IL-1α、IL-1β、IL-2、IL-6和TNFα低于对照PBMCs,而IL-4、IL-10和IFNγ的产生高于对照PBMCs。腹腔和胸腔积液中IL-1α、IL-1β和IL-4的浓度与自体血清中测得的浓度无差异,而IL-6、IL-10、TNFα、IFNγ和sIL-2R的浓度显著更高。胸腔积液中IL-2的量与自体血清中的量无差异,但腹腔积液中IL-2的量高于自体血清。患者血清中IL-1α、IL-1β、IL-2、IL-6、TNFα和sIL-2R的量高于对照血清,而IL-4、IL-10和IFNγ在患者血清和对照血清中的量处于同一范围。对培养的TALMs和PBMCs(来自3例患者)进行细胞周期分析显示,与自体PBMCs相比,TALMs在非循环G0/G1细胞群体中显著积累。